AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21273395 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 19585577 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Mel‐18 expression
Number of subjects: 393
Study 19585577 — intervention group
Group type: EXPERIMENTAL
Intervention: Homozygous G allele genotype
Number of subjects: 393
Study 19585577 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative Mel‐18 expression
Number of subjects: 393
Study 19585577 — intervention group
Group type: EXPERIMENTAL
Intervention: G allele
Number of subjects: 393
Study 17227787 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinolysis
Number of subjects: 1017
Study 17227787 — intervention group
Group type: COMPARATOR
Intervention: Primary Angioplasty
Number of subjects: 1017
Study 15381586 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous access
Number of subjects: 100
Study 15381586 — intervention group
Group type: COMPARATOR
Intervention: No intravenous access
Number of subjects: 100
Study 12364845 — intervention group
Group type: EXPERIMENTAL
Intervention: Go/NoGo task
Number of subjects: 19
Study 12364845 — intervention group
Group type: EXPERIMENTAL
Intervention: fMRI data analysis
Number of subjects: 19
Study 10518849 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal Toothpaste and Gum Therapy
Number of subjects: 40
Study 10518849 — intervention group
Group type: COMPARATOR
Intervention: Colgate Total
Number of subjects: 40
Study 8125413 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg Parlodel SRO
Number of subjects: 20
Study 8125413 — intervention group
Group type: COMPARATOR
Intervention: 2.5 mg Parlodel b.i.d.
Number of subjects: 20
Study 8125413 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg Parlodel SRO (single dose)
Number of subjects: 20
Study 8125413 — intervention group
Group type: COMPARATOR
Intervention: 10 mg Parlodel (two doses of 5 mg)
Number of subjects: 20
Study 2570001 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg acrivastine three times daily
Number of subjects: 0
Study 2570001 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2570001 — intervention group
Group type: COMPARATOR
Intervention: Acrivastine and Placebo
Number of subjects: 0
Study 70149 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (maintenance dose 15 mg/day)
Number of subjects: 54
Study 70149 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticotrophin (maintenance dose 1 mg/week, i.m.)
Number of subjects: 54
Study 31544345 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Behavioral Therapy (IBT) protocol
Number of subjects: 50
Study 28623944 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy (MT) that includes spinal manipulative therapy (SMT) plus standardised exercise program
Number of subjects: 202
Study 28623944 — intervention group
Group type: COMPARATOR
Intervention: Standardised exercise program
Number of subjects: 202
Study 25527253 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine XR
Number of subjects: 123
Study 25527253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study 23414061 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalazine 1000 mg three times daily
Number of subjects: 117
Study 23414061 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study 21675064 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedation with propofol infusion (10 to 20 mg x hour), n = 20
Number of subjects: 40
Study 21675064 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia using sub minimum alveolar concentration of sevoflurane, n = 20
Number of subjects: 40
Study 21675064 — intervention group
Group type: COMPARATOR
Intervention: Beachchair positioning during general anaesthesia
Number of subjects: 40
Study 19368793 — intervention group
Group type: EXPERIMENTAL
Intervention: 4microg Trivalent influenza DNA vaccine
Number of subjects: 54
Study 19368793 — intervention group
Group type: EXPERIMENTAL
Intervention: 2microg Trivalent influenza DNA vaccine plus DEI‐LT
Number of subjects: 54
Study 19368793 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 16940406 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat 60 mg, given 3 times daily
Number of subjects: 391
Study 16940406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 391
Study 14690727 — intervention group
Group type: EXPERIMENTAL
Intervention: Biatrial synchronous pacing (BAP) for 72 h postoperatively (n=40)
Number of subjects: 80
Study 14690727 — intervention group
Group type: COMPARATOR
Intervention: No atrial pacing (controls; n=40)
Number of subjects: 80
Study 11351931 — intervention group
Group type: EXPERIMENTAL
Intervention: Active alcoholics
Number of subjects: 46
Study 11351931 — intervention group
Group type: EXPERIMENTAL
Intervention: Currently abstinent alcoholics
Number of subjects: 46
Study 11351931 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 46
Study 11351931 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol rewards
Number of subjects: 46
Study 8988820 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (M)
Number of subjects: 40
Study 8988820 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (P)
Number of subjects: 40
Study 8988820 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study 8100044 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg modafinil b.i.d.
Number of subjects: 40
Study 8100044 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 3574692 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciladopa (added to levodopa)
Number of subjects: 31
Study 29316004 — intervention group
Group type: EXPERIMENTAL
Intervention: CMAC videolaryngoscope
Number of subjects: 64
Study 29316004 — intervention group
Group type: COMPARATOR
Intervention: Miller laryngoscope
Number of subjects: 64
Study 27262412 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 102
Study 27262412 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study 23965000 — intervention group
Group type: EXPERIMENTAL
Intervention: mTBI patients
Number of subjects: 30
Study 23965000 — intervention group
Group type: COMPARATOR
Intervention: HC
Number of subjects: 30
Study 23774725 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback combined with conventional treatment
Number of subjects: 0
Study 23774725 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment alone
Number of subjects: 0
Study 20221770 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (PGB) as mono- or add-on therapy, flexible-dosage, administered twice daily
Number of subjects: 187
Study 20221770 — intervention group
Group type: COMPARATOR
Intervention: Non-Pregabalin therapy (change established doses and combinations of pre-existing mono- or combination therapy)
Number of subjects: 187
Study 18677810 — intervention group
Group type: EXPERIMENTAL
Intervention: Fengweicao Granule (FWCG), 5 g orally twice a day for 3 months
Number of subjects: 155
Study 18677810 — intervention group
Group type: COMPARATOR
Intervention: Proscar, 5 mg per day for 3 months
Number of subjects: 155
Study 18677810 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (FWCG and Proscar)
Number of subjects: 155
Study 16911387 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol/betamethasone dipropionate ointment (Daivobet/Dovobet)
Number of subjects: 0
Study 16911387 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone dipropionate
Number of subjects: 0
Study 16911387 — intervention group
Group type: COMPARATOR
Intervention: Calcipotriol
Number of subjects: 0
Study 16911387 — intervention group
Group type: COMPARATOR
Intervention: Ointment vehicle
Number of subjects: 0
Study 16911387 — intervention group
Group type: COMPARATOR
Intervention: Efalizumab
Number of subjects: 0
Study 16911387 — intervention group
Group type: COMPARATOR
Intervention: Etanercept
Number of subjects: 0
Study 16911387 — intervention group
Group type: COMPARATOR
Intervention: Alefacept
Number of subjects: 0
Study 12930031 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient counseling on drug, diseases, and lifestyle modification from a pharmacist after a hospital visit.
Number of subjects: 78
Study 12930031 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient counseling
Number of subjects: 78
Study 12243720 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot orthosis
Number of subjects: 12
Study 12243720 — intervention group
Group type: COMPARATOR
Intervention: Heel wedge
Number of subjects: 12
Study 12243720 — intervention group
Group type: COMPARATOR
Intervention: Normal footwear
Number of subjects: 12
Study 9776857 — intervention group
Group type: EXPERIMENTAL
Intervention: Inducible nitric oxide synthase expression in keratinocytes at the edge of the wounds
Number of subjects: 29
Study 9776857 — intervention group
Group type: EXPERIMENTAL
Intervention: Inducible nitric oxide synthase expression in proliferative keratinocytes and hair follicles
Number of subjects: 29
Study 9776857 — intervention group
Group type: EXPERIMENTAL
Intervention: Inducible nitric oxide synthase expression in granulation tissue
Number of subjects: 29
Study 9776857 — intervention group
Group type: EXPERIMENTAL
Intervention: Inducible nitric oxide synthase expression in association with inflammatory infiltrates
Number of subjects: 29
Study 9776857 — intervention group
Group type: COMPARATOR
Intervention: Noninjured skin
Number of subjects: 29
Study 8068968 — intervention group
Group type: EXPERIMENTAL
Intervention: Mark-sheet method (MSM)
Number of subjects: 463
Study 8068968 — intervention group
Group type: COMPARATOR
Intervention: Manual method (MM)
Number of subjects: 463
Study 3073356 — intervention group
Group type: EXPERIMENTAL
Intervention: Legalon (MADAUS, FRG) t.i.d. for 30 days
Number of subjects: 200
Study 3073356 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 200
Study 31952367 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic forces applied using a closed-coil spring for 2 days
Number of subjects: 0
Study 31952367 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic forces applied using a closed-coil spring for 7 days
Number of subjects: 0
Study 31952367 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic forces applied using a closed-coil spring for 14 days
Number of subjects: 0
Study 31074205 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin (100 mg/day)
Number of subjects: 34
Study 31074205 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 34
Study 29133282 — intervention group
Group type: EXPERIMENTAL
Intervention: Web 2.0 intervention
Number of subjects: 1328
Study 29133282 — intervention group
Group type: COMPARATOR
Intervention: Web 1.0 intervention
Number of subjects: 1328
Study 29133282 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1328
Study 25048668 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra PE (four extra physical education lessons per week)
Number of subjects: 1247
Study 25048668 — intervention group
Group type: COMPARATOR
Intervention: Normal PE (control group)
Number of subjects: 1247
Study 23542898 — intervention group
Group type: EXPERIMENTAL
Intervention: Human apoC‐III antisense drug
Number of subjects: 0
Study 23542898 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20796260 — intervention group
Group type: EXPERIMENTAL
Intervention: Optyse lens‐free ophthalmoscope
Number of subjects: 20
Study 20796260 — intervention group
Group type: COMPARATOR
Intervention: Keeler pocket ophthalmoscope
Number of subjects: 20
Study 20092085 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard clinical CPB circuits with EDAC system probes
Number of subjects: 12
Study 16641119 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smokers (n = 35)
Number of subjects: 221
Study 16641119 — intervention group
Group type: EXPERIMENTAL
Intervention: Ex-smokers (n = 75)
Number of subjects: 221
Study 16641119 — intervention group
Group type: EXPERIMENTAL
Intervention: Snus (oral moist snuff) consumption (n = 21) in ex-smokers
Number of subjects: 221
Study 16641119 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive smoking
Number of subjects: 221
Study 16641119 — intervention group
Group type: COMPARATOR
Intervention: Current smoking
Number of subjects: 221
Study 14964926 — intervention group
Group type: EXPERIMENTAL
Intervention: Office reminder systems (flowsheets with mammography prompts, nonphysician staff identification, computerized reminder systems)
Number of subjects: 24030
Study 14964926 — intervention group
Group type: COMPARATOR
Intervention: Urban practices
Number of subjects: 24030
Study 11718043 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative culture (QC)
Number of subjects: 31
Study 11718043 — intervention group
Group type: COMPARATOR
Intervention: Qualitative routine culture (RC)
Number of subjects: 31
Study 11718043 — intervention group
Group type: EXPERIMENTAL
Intervention: Inappropriate initial empirical antibiotic treatment
Number of subjects: 31
Study 9254255 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomes with antibiotics and ectericide
Number of subjects: 120
Study 8129908 — intervention group
Group type: EXPERIMENTAL
Intervention: Engerix B (SK&F)
Number of subjects: 640
Study 8129908 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombivax HB (MSD)
Number of subjects: 640
Study 8129908 — intervention group
Group type: COMPARATOR
Intervention: One type of vaccine
Number of subjects: 640
Study 2447056 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlormadinone acetate (CMA)
Number of subjects: 16
Study 2447056 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA)
Number of subjects: 16
Study 2447056 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 31479015 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 28720395 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (ACZ)
Number of subjects: 84
Study 28720395 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 84
Study 28720395 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ACZ and NAC
Number of subjects: 84
Study 28720395 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 25962400 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 4 mg/kg
Number of subjects: 80
Study 25962400 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 2 mg/kg
Number of subjects: 80
Study 23237605 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01 mg.kg(‐1) penehyclidine hydrochloride
Number of subjects: 920
Study 23237605 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 920
Study 21753869 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss plus exercise (WL+E)
Number of subjects: 34
Study 21753869 — intervention group
Group type: COMPARATOR
Intervention: Educational control
Number of subjects: 34
Study 19426555 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure (PEEP) levels between 0 and 15 cmH2O
Number of subjects: 35
Study 19426555 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure (PEEP) levels
Number of subjects: 35
Study 19426555 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated measurements of lung sounds
Number of subjects: 35
Study 16369129 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) 1 x 300 or 480 microg s.c. prior to standard antibiotic treatment
Number of subjects: 16
Study 16369129 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment only (control group)
Number of subjects: 16
Study 15151666 — intervention group
Group type: EXPERIMENTAL
Intervention: White wine
Number of subjects: 14
Study 15151666 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine
Number of subjects: 14
Study 15151666 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline measurement)
Number of subjects: 14
Study 11168137 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 178
Study 11168137 — intervention group
Group type: COMPARATOR
Intervention: Imipenem/cilastatin
Number of subjects: 178
Study 9120927 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 556
Study 9120927 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting
Number of subjects: 556
Study 7920884 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with chronic thyroiditis
Number of subjects: 0
Study 7920884 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 0
Study 3539615 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 0
Study 3539615 — intervention group
Group type: COMPARATOR
Intervention: Prazosin
Number of subjects: 0
Study 31987684 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative education on mechanical ventilation and communication panel usage
Number of subjects: 200
Study 31987684 — intervention group
Group type: COMPARATOR
Intervention: No education
Number of subjects: 200
Study 29538636 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate ART with Efavirenz (EFV)
Number of subjects: 4684
Study 29538636 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate ART with other prespecified regimens
Number of subjects: 4684
Study 29538636 — intervention group
Group type: COMPARATOR
Intervention: Deferred ART
Number of subjects: 4684
Study 27421759 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive tailored informational messages about sustainable healthy eating delivered via a mobile smartphone app
Number of subjects: 0
Study 27421759 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative longitudinal research to explore openness to adopting sustainable healthy eating behaviour
Number of subjects: 0
Study 27421759 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative research to develop a sustainable healthy eating behaviour index
Number of subjects: 0
Study 27421759 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised controlled trial
Number of subjects: 0
Study 23445173 — intervention group
Group type: EXPERIMENTAL
Intervention: 2BOD (ball attachment on two implants)
Number of subjects: 18
Study 23445173 — intervention group
Group type: EXPERIMENTAL
Intervention: 2ROD (bar attachment on two implants)
Number of subjects: 18
Study 23445173 — intervention group
Group type: EXPERIMENTAL
Intervention: 4ROD (bar attachments on four implants)
Number of subjects: 18
Study 23445173 — intervention group
Group type: COMPARATOR
Intervention: CD (control, conventional dentures)
Number of subjects: 18
Study 23328326 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis (hypnotic analgesia suggestions)
Number of subjects: 41
Study 23328326 — intervention group
Group type: COMPARATOR
Intervention: Control (relaxation)
Number of subjects: 41
Study 23328326 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline somatosensory sensitivity
Number of subjects: 41
Study 20492050 — intervention group
Group type: EXPERIMENTAL
Intervention: Preferred music listening intervention (30-minute sessions, twice a week for six weeks)
Number of subjects: 52
Study 20492050 — intervention group
Group type: COMPARATOR
Intervention: Usual standard care with no music
Number of subjects: 52
Study 17691577 — intervention group
Group type: EXPERIMENTAL
Intervention: Otopoint-penetrative needling
Number of subjects: 98
Study 17691577 — intervention group
Group type: COMPARATOR
Intervention: Otopoint-straight needling
Number of subjects: 98
Study 15186869 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive computer-based hypoglycaemia education program
Number of subjects: 120
Study 15186869 — intervention group
Group type: COMPARATOR
Intervention: Conventional computer-based hypoglycaemia education program
Number of subjects: 120
Study 11480943 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial support and basic medical care (n = 42)
Number of subjects: 87
Study 11480943 — intervention group
Group type: COMPARATOR
Intervention: Medical care only (n = 45)
Number of subjects: 87
Study 9751091 — intervention group
Group type: EXPERIMENTAL
Intervention: SC-58635
Number of subjects: 0
Study 9751091 — intervention group
Group type: COMPARATOR
Intervention: naproxen
Number of subjects: 0
Study 9751091 — intervention group
Group type: COMPARATOR
Intervention: aspirin
Number of subjects: 0
Study 8150115 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin-releasing hormone agonist (GnRH‐a) discontinued as gonadotropin stimulation began
Number of subjects: 173
Study 8150115 — intervention group
Group type: COMPARATOR
Intervention: Gonadotropin-releasing hormone agonist (GnRH‐a) continued as gonadotropin stimulation began
Number of subjects: 173
Study 3258170 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI)
Number of subjects: 22
Study 31446416 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapist-led behavioural change intervention (MOSAIC)
Number of subjects: 192
Study 31446416 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 192
Study 29876530 — intervention group
Group type: EXPERIMENTAL
Intervention: (Pyr(1))apelin‐13 infusion
Number of subjects: 19
Study 29876530 — intervention group
Group type: EXPERIMENTAL
Intervention: (Pyr(1))apelin‐13 infusion with concomitant phosphodiesterase type 5 inhibition
Number of subjects: 19
Study 29876530 — intervention group
Group type: COMPARATOR
Intervention: saline placebo
Number of subjects: 19
Study 27178989 — intervention group
Group type: EXPERIMENTAL
Intervention: RemoweLL cardiotomy reservoir
Number of subjects: 45
Study 27178989 — intervention group
Group type: COMPARATOR
Intervention: Admiral cardiotomy reservoir
Number of subjects: 45
Study 25160890 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive speed of processing training (SPT)
Number of subjects: 0
Study 25160890 — intervention group
Group type: COMPARATOR
Intervention: Social- and computer-contact control group
Number of subjects: 0
Study 22982658 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib (400 mg orally twice daily for 2 months)
Number of subjects: 299
Study 22982658 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299
Study 22982658 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib
Number of subjects: 299
Study 20012601 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral lovastatin (20 mg)
Number of subjects: 14